AYKAÇ, M. Et Al. 2024. Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , no.9 , 1124-1133.

AYKAÇ, M., BALKAN, E., GEDİKLİ, S., & ÖZTÜRK, N., (2024). Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , no.9, 1124-1133.

AYKAÇ, Merve Et Al. "Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model," IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , no.9, 1124-1133, 2024

AYKAÇ, Merve Et Al. "Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model." IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , no.9, pp.1124-1133, 2024

AYKAÇ, M. Et Al. (2024) . "Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model." IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES , no.9, pp.1124-1133.

@article{article, author={Merve AYKAÇ Et Al. }, title={Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model}, journal={IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES}, year=2024, pages={1124-1133} }